New hope for tough prostate cancer: experimental therapy targets resistant tumors
NCT ID NCT06533644
Summary
This study is testing a new immunotherapy called SV-102 for men with advanced prostate cancer that has spread and stopped responding to standard hormone treatments. Researchers will give the treatment directly into tumors to find the safest and most effective dose while checking if it helps shrink cancer. The goal is to control the disease in patients who have few remaining treatment options.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC CASTRATION RESISTANT PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
Duly Health
RECRUITINGLisle, Illinois, 60532, United States
-
Mercy Hospital
RECRUITINGSt Louis, Missouri, 63141, United States
-
Michigan Institute of Urology
RECRUITINGTroy, Michigan, 48084, United States
-
Northwell Health
RECRUITINGLake Success, New York, 11042, United States
-
University of Arizona Cancer Center
RECRUITINGTucson, Arizona, 85719, United States
-
University of Nebraska Medical Center
RECRUITINGOmaha, Nebraska, 68105, United States
-
University of Pittsburgh Medical Center
RECRUITINGPittsburgh, Pennsylvania, 15213, United States
-
Weill Cornell
RECRUITINGNew York, New York, 10065, United States
-
Wichita Urology
RECRUITINGWichita, Kansas, 67226, United States
Conditions
Explore the condition pages connected to this study.